<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC6706343</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC6706343.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">6706343</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">6706343</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">31421507</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1016/j.nicl.2019.101975</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">S2213-1582(19)30325-0</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">101975</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Cross-sectional demographic and clinical characteristics, and gait performance of the Gait and Brain participants included in this study.</table-caption><table-wrap-foot>* indicates p value was obtained by running ANCOVA using age, sex, BMI, years of education and MMSE scores as confounding variables of no interest. Mean ± standard deviation where applicable; (% of N listed at top of column); [range: minimum to maximum].</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="t0005" orientation="portrait"><label>Table 1</label><caption><p>Cross-sectional demographic and clinical characteristics, and gait performance of the Gait and Brain participants included in this study.</p></caption><alt-text id="al0030">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Demographics</th><th colspan="1" rowspan="1">Full sample <italic toggle="yes">N</italic> = 43</th><th colspan="1" rowspan="1">Non-Fallers <italic toggle="yes">N</italic> = 26</th><th colspan="1" rowspan="1">Fallers <italic toggle="yes">N</italic> = 17</th><th colspan="1" rowspan="1"><italic toggle="yes">p</italic> value</th><th colspan="1" rowspan="1"><italic toggle="yes">p</italic> value*</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Age (mean ± SD)</td><td colspan="1" rowspan="1">74.5 ± 5.9 [63–87]</td><td colspan="1" rowspan="1">74.2 ± 5.9 [63–84]</td><td colspan="1" rowspan="1">75 ± 6.1 [66–87]</td><td colspan="1" rowspan="1">0.41</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1">Sex, # of females (%)</td><td colspan="1" rowspan="1">18 (41.9%)</td><td colspan="1" rowspan="1">12 (46.2%)</td><td colspan="1" rowspan="1">6 (35.3%)</td><td colspan="1" rowspan="1">0.52</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1">BMI</td><td colspan="1" rowspan="1">26 ± 4.1 [19–36]</td><td colspan="1" rowspan="1">25.2 ± 4 [19–33]</td><td colspan="1" rowspan="1">27.2 ± 4.1 [21–36]</td><td colspan="1" rowspan="1">0.35</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1">Years of Education</td><td colspan="1" rowspan="1">13.3 ± 2.6 [8–20]</td><td colspan="1" rowspan="1">13.3 ± 1.9 [10–18]</td><td colspan="1" rowspan="1">13.3 ± 3.4 [8–20]</td><td colspan="1" rowspan="1">0.93</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1">Cognitive performance</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"> MMSE</td><td colspan="1" rowspan="1">27.4 ± 2.5 [20−30]</td><td colspan="1" rowspan="1">26.7 ± 2.7 [20–30]</td><td colspan="1" rowspan="1">28.5 ± 1.7 [24–30]</td><td colspan="1" rowspan="1">0.30</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> MoCA</td><td colspan="1" rowspan="1">23.7 ± 3.7 [12−30]</td><td colspan="1" rowspan="1">23.3 ± 4.1 [12–30]</td><td colspan="1" rowspan="1">24.2 ± 3.1 [19–29]</td><td colspan="1" rowspan="1">0.58</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1">Comorbidities</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"> Number of Comorbidities</td><td colspan="1" rowspan="1">5.7 ± 2.8 [0−13]</td><td colspan="1" rowspan="1">5.6 ± 3.4 [0–13]</td><td colspan="1" rowspan="1">5.8 ± 2.5 [0−11]</td><td colspan="1" rowspan="1">0.87</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> hypertension</td><td colspan="1" rowspan="1">21 (48.8%)</td><td colspan="1" rowspan="1">14 (53.8%)</td><td colspan="1" rowspan="1">7 (41.2%)</td><td colspan="1" rowspan="1">0.53</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> Diabetes</td><td colspan="1" rowspan="1">7 (16.3%)</td><td colspan="1" rowspan="1">4 (15.4%)</td><td colspan="1" rowspan="1">3 (17.6%)</td><td colspan="1" rowspan="1">0.68</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> Osteoporosis</td><td colspan="1" rowspan="1">7 (16.3%)</td><td colspan="1" rowspan="1">4 (15.4%)</td><td colspan="1" rowspan="1">3 (17.6%)</td><td colspan="1" rowspan="1">0.68</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> Chronic Lung Disease</td><td colspan="1" rowspan="1">3 (7%)</td><td colspan="1" rowspan="1">3 (11.5%)</td><td colspan="1" rowspan="1">0 (0%)</td><td colspan="1" rowspan="1">0.54</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> Osteoarthritis</td><td colspan="1" rowspan="1">13 (30.2%)</td><td colspan="1" rowspan="1">7 (26.9%)</td><td colspan="1" rowspan="1">6 (35.3%)</td><td colspan="1" rowspan="1">0.74</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> Cancer</td><td colspan="1" rowspan="1">15 (34.9%)</td><td colspan="1" rowspan="1">11 (42.3%)</td><td colspan="1" rowspan="1">4 (23.5%)</td><td colspan="1" rowspan="1">0.19</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> Hearing Problems</td><td colspan="1" rowspan="1">19 (44.2%)</td><td colspan="1" rowspan="1">11 (42.3%)</td><td colspan="1" rowspan="1">8 (47.1%)</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> Depression</td><td colspan="1" rowspan="1">12 (27.9%)</td><td colspan="1" rowspan="1">7 (26.9%)</td><td colspan="1" rowspan="1">5 (29.4%)</td><td colspan="1" rowspan="1">0.72</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> Stroke</td><td colspan="1" rowspan="1">3 (7%)</td><td colspan="1" rowspan="1">1 (3.8%)</td><td colspan="1" rowspan="1">2 (11.8%)</td><td colspan="1" rowspan="1">0.28</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> Visual Impairment</td><td colspan="1" rowspan="1">40 (93%)</td><td colspan="1" rowspan="1">24 (92.3%)</td><td colspan="1" rowspan="1">16 (94.1%)</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> CHF/MI/Angina</td><td colspan="1" rowspan="1">2 (4.7%)</td><td colspan="1" rowspan="1">1 (3.8%)</td><td colspan="1" rowspan="1">1 (5.9%)</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> Atrial fibrillation</td><td colspan="1" rowspan="1">2 (4.7%)</td><td colspan="1" rowspan="1">1 (3.8%)</td><td colspan="1" rowspan="1">1 (5.9%)</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1">WMH</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"> Volume of WMH (mL)</td><td colspan="1" rowspan="1">12.3 ± 3.0</td><td colspan="1" rowspan="1">11.8 ± 2.0</td><td colspan="1" rowspan="1">13.2 ± 4.3</td><td colspan="1" rowspan="1">0.437</td><td colspan="1" rowspan="1">0.28</td></tr><tr><td colspan="1" rowspan="1">Quantitative Gait</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"> Usual Gait Velocity (mean ± SD) cm/s</td><td colspan="1" rowspan="1">108.2 ± 21.3 [57–165]</td><td colspan="1" rowspan="1">109.6 ± 19.8 [66–151]</td><td colspan="1" rowspan="1">106 ± 23.8 [57–165]</td><td colspan="1" rowspan="1">0.26</td><td colspan="1" rowspan="1">0.09</td></tr><tr><td colspan="1" rowspan="1"> Counting gait velocity cm/s</td><td colspan="1" rowspan="1">103.9 ± 26.8 [44–177]</td><td colspan="1" rowspan="1">105.5 ± 26.4 [61–167]</td><td colspan="1" rowspan="1">101.3 ± 28 [44–177]</td><td colspan="1" rowspan="1">0.20</td><td colspan="1" rowspan="1">0.03</td></tr><tr><td colspan="1" rowspan="1"> Serial 7 s velocity cm/s</td><td colspan="1" rowspan="1">90.5 ± 30.8 [37–181]</td><td colspan="1" rowspan="1">89.7 ± 31.2 [37–168]</td><td colspan="1" rowspan="1">91.7 ± 31.3 [39–181]</td><td colspan="1" rowspan="1">0.59</td><td colspan="1" rowspan="1">0.16</td></tr><tr><td colspan="1" rowspan="1"> Naming animals velocity cm/s</td><td colspan="1" rowspan="1">92.7 ± 27.9 [35–170]</td><td colspan="1" rowspan="1">90.5 ± 28.7 [49–170]</td><td colspan="1" rowspan="1">96.1 ± 27.1 [35–163]</td><td colspan="1" rowspan="1">0.73</td><td colspan="1" rowspan="1">0.38</td></tr></tbody></table><table-wrap-foot><fn><p>* indicates <italic toggle="yes">p</italic> value was obtained by running ANCOVA using age, sex, BMI, years of education and MMSE scores as confounding variables of no interest. Mean ± standard deviation where applicable; (% of N listed at top of column); [range: minimum to maximum].</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Cross-sectional demographic and clinical characteristics, and gait performance of the Gait and Brain participants included in this study.</div>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Demographics</th><th>Full sample N = 43</th><th>Non-Fallers N = 26</th><th>Fallers N = 17</th><th>p value</th><th>p value*</th></tr></thead><tbody><tr><td>Age (mean ± SD)</td><td>74.5 ± 5.9 [63–87]</td><td>74.2 ± 5.9 [63–84]</td><td>75 ± 6.1 [66–87]</td><td>0.41</td><td>–</td></tr><tr><td>Sex, # of females (%)</td><td>18 (41.9%)</td><td>12 (46.2%)</td><td>6 (35.3%)</td><td>0.52</td><td>–</td></tr><tr><td>BMI</td><td>26 ± 4.1 [19–36]</td><td>25.2 ± 4 [19–33]</td><td>27.2 ± 4.1 [21–36]</td><td>0.35</td><td>–</td></tr><tr><td>Years of Education</td><td>13.3 ± 2.6 [8–20]</td><td>13.3 ± 1.9 [10–18]</td><td>13.3 ± 3.4 [8–20]</td><td>0.93</td><td>–</td></tr><tr><td>Cognitive performance</td><td/><td/><td/><td/><td/></tr><tr><td> MMSE</td><td>27.4 ± 2.5 [20−30]</td><td>26.7 ± 2.7 [20–30]</td><td>28.5 ± 1.7 [24–30]</td><td>0.30</td><td>–</td></tr><tr><td> MoCA</td><td>23.7 ± 3.7 [12−30]</td><td>23.3 ± 4.1 [12–30]</td><td>24.2 ± 3.1 [19–29]</td><td>0.58</td><td>–</td></tr><tr><td>Comorbidities</td><td/><td/><td/><td/><td/></tr><tr><td> Number of Comorbidities</td><td>5.7 ± 2.8 [0−13]</td><td>5.6 ± 3.4 [0–13]</td><td>5.8 ± 2.5 [0−11]</td><td>0.87</td><td>–</td></tr><tr><td> hypertension</td><td>21 (48.8%)</td><td>14 (53.8%)</td><td>7 (41.2%)</td><td>0.53</td><td>–</td></tr><tr><td> Diabetes</td><td>7 (16.3%)</td><td>4 (15.4%)</td><td>3 (17.6%)</td><td>0.68</td><td>–</td></tr><tr><td> Osteoporosis</td><td>7 (16.3%)</td><td>4 (15.4%)</td><td>3 (17.6%)</td><td>0.68</td><td>–</td></tr><tr><td> Chronic Lung Disease</td><td>3 (7%)</td><td>3 (11.5%)</td><td>0 (0%)</td><td>0.54</td><td>–</td></tr><tr><td> Osteoarthritis</td><td>13 (30.2%)</td><td>7 (26.9%)</td><td>6 (35.3%)</td><td>0.74</td><td>–</td></tr><tr><td> Cancer</td><td>15 (34.9%)</td><td>11 (42.3%)</td><td>4 (23.5%)</td><td>0.19</td><td>–</td></tr><tr><td> Hearing Problems</td><td>19 (44.2%)</td><td>11 (42.3%)</td><td>8 (47.1%)</td><td>1.00</td><td>–</td></tr><tr><td> Depression</td><td>12 (27.9%)</td><td>7 (26.9%)</td><td>5 (29.4%)</td><td>0.72</td><td>–</td></tr><tr><td> Stroke</td><td>3 (7%)</td><td>1 (3.8%)</td><td>2 (11.8%)</td><td>0.28</td><td>–</td></tr><tr><td> Visual Impairment</td><td>40 (93%)</td><td>24 (92.3%)</td><td>16 (94.1%)</td><td>1.00</td><td>–</td></tr><tr><td> CHF/MI/Angina</td><td>2 (4.7%)</td><td>1 (3.8%)</td><td>1 (5.9%)</td><td>1.00</td><td>–</td></tr><tr><td> Atrial fibrillation</td><td>2 (4.7%)</td><td>1 (3.8%)</td><td>1 (5.9%)</td><td>1.00</td><td>–</td></tr><tr><td>WMH</td><td/><td/><td/><td/><td/></tr><tr><td> Volume of WMH (mL)</td><td>12.3 ± 3.0</td><td>11.8 ± 2.0</td><td>13.2 ± 4.3</td><td>0.437</td><td>0.28</td></tr><tr><td>Quantitative Gait</td><td/><td/><td/><td/><td/></tr><tr><td> Usual Gait Velocity (mean ± SD) cm/s</td><td>108.2 ± 21.3 [57–165]</td><td>109.6 ± 19.8 [66–151]</td><td>106 ± 23.8 [57–165]</td><td>0.26</td><td>0.09</td></tr><tr><td> Counting gait velocity cm/s</td><td>103.9 ± 26.8 [44–177]</td><td>105.5 ± 26.4 [61–167]</td><td>101.3 ± 28 [44–177]</td><td>0.20</td><td>0.03</td></tr><tr><td> Serial 7 s velocity cm/s</td><td>90.5 ± 30.8 [37–181]</td><td>89.7 ± 31.2 [37–168]</td><td>91.7 ± 31.3 [39–181]</td><td>0.59</td><td>0.16</td></tr><tr><td> Naming animals velocity cm/s</td><td>92.7 ± 27.9 [35–170]</td><td>90.5 ± 28.7 [49–170]</td><td>96.1 ± 27.1 [35–163]</td><td>0.73</td><td>0.38</td></tr></tbody></table></div>* indicates p value was obtained by running ANCOVA using age, sex, BMI, years of education and MMSE scores as confounding variables of no interest. Mean ± standard deviation where applicable; (% of N listed at top of column); [range: minimum to maximum].</transformed-table></extracted-table><extracted-table><table-id>t0010</table-id><table-label>Table 2</table-label><table-caption>Association between WMI as a predictor variable and previous number of falls.</table-caption><table-wrap-foot>* Significant at the p &lt; 0.05 level; ** significant at the p &lt; 0.01 level; unadjusted model uses the RD of the forceps minor to predict number of falls. † adjusted for age, number of years of education, gender, BMI and MMSE scores and number of comorbidities †† adjusted for age, number of years of education, gender, BMI and MMSE scores, number of comorbidities and counting gait velocity ††† adjusted for age, number of years of education, gender, BMI and MMSE scores, number of comorbidities, counting gait velocity and WMH volume. χ2 - Likelihood Ratio Chi-Square, df - degrees of freedom.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="t0010" orientation="portrait"><label>Table 2</label><caption><p>Association between WMI as a predictor variable and previous number of falls.</p></caption><alt-text id="al0035">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th colspan="1" rowspan="1">Unadjusted<hr/></th><th colspan="1" rowspan="1">Adjusted†<hr/></th><th colspan="1" rowspan="1">Adjusted††<hr/></th><th colspan="1" rowspan="1">Adjusted†††<hr/></th></tr><tr><th colspan="1" rowspan="1">χ<sup>2</sup> (df)<break/><italic toggle="yes">p</italic> value</th><th colspan="1" rowspan="1">χ<sup>2</sup> (df)<break/><italic toggle="yes">p</italic> value</th><th colspan="1" rowspan="1">χ<sup>2</sup> (df)<break/><italic toggle="yes">p</italic> value</th><th colspan="1" rowspan="1">χ<sup>2</sup> (df)<break/><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Number of falls (n = 43)</td><td colspan="1" rowspan="1">6.335 (1)<break/>0.012*</td><td colspan="1" rowspan="1">15.676 (7)<break/>0.028*</td><td colspan="1" rowspan="1">19.777 (8)<break/>0.011*</td><td colspan="1" rowspan="1">25.162 (9)<break/>0.003**</td></tr></tbody></table><table-wrap-foot><fn><p>* Significant at the p &lt; 0.05 level; ** significant at the <italic toggle="yes">p</italic> &lt; 0.01 level; unadjusted model uses the RD of the forceps minor to predict number of falls. † adjusted for age, number of years of education, gender, BMI and MMSE scores and number of comorbidities †† adjusted for age, number of years of education, gender, BMI and MMSE scores, number of comorbidities and counting gait velocity ††† adjusted for age, number of years of education, gender, BMI and MMSE scores, number of comorbidities, counting gait velocity and WMH volume. χ<sup>2</sup> - Likelihood Ratio Chi-Square, df - degrees of freedom.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Association between WMI as a predictor variable and previous number of falls.</div>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th>Unadjusted</th><th>Adjusted†</th><th>Adjusted††</th><th>Adjusted†††</th></tr><tr><th>χ2 (df)p value</th><th>χ2 (df)p value</th><th>χ2 (df)p value</th><th>χ2 (df)p value</th></tr></thead><tbody><tr><td>Number of falls (n = 43)</td><td>6.335 (1)0.012*</td><td>15.676 (7)0.028*</td><td>19.777 (8)0.011*</td><td>25.162 (9)0.003**</td></tr></tbody></table></div>* Significant at the p &lt; 0.05 level; ** significant at the p &lt; 0.01 level; unadjusted model uses the RD of the forceps minor to predict number of falls. † adjusted for age, number of years of education, gender, BMI and MMSE scores and number of comorbidities †† adjusted for age, number of years of education, gender, BMI and MMSE scores, number of comorbidities and counting gait velocity ††† adjusted for age, number of years of education, gender, BMI and MMSE scores, number of comorbidities, counting gait velocity and WMH volume. χ2 - Likelihood Ratio Chi-Square, df - degrees of freedom.</transformed-table></extracted-table><extracted-table><table-id>t0015</table-id><table-label>Table 3</table-label><table-caption>Parameters estimates for negative binomial regression with multiple predictors.</table-caption><table-wrap-foot>⁎Significant at the p &lt; .05 level (in bold); IRR: Incident Rate Ratios.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="t0015" orientation="portrait"><label>Table 3</label><caption><p>Parameters estimates for negative binomial regression with multiple predictors.</p></caption><alt-text id="al0040">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Parameter</th><th rowspan="2" colspan="1">Sig.</th><th rowspan="2" colspan="1">IRR</th><th colspan="2" rowspan="1">95% Confidence Interval for IRR<hr/></th></tr><tr><th colspan="1" rowspan="1">Lower</th><th colspan="1" rowspan="1">Upper</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">RD ForcepsMin (10<sup>7</sup> μm<sup>2</sup>/s)</td><td colspan="1" rowspan="1"><bold>0.02</bold><xref rid="tf0005" ref-type="table-fn">⁎</xref></td><td colspan="1" rowspan="1">1.02</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">1.04</td></tr><tr><td colspan="1" rowspan="1">Gender</td><td colspan="1" rowspan="1">0.12</td><td colspan="1" rowspan="1">3.24</td><td colspan="1" rowspan="1">0.74</td><td colspan="1" rowspan="1">14.18</td></tr><tr><td colspan="1" rowspan="1">Age (yrs)</td><td colspan="1" rowspan="1">0.16</td><td colspan="1" rowspan="1">0.89</td><td colspan="1" rowspan="1">0.75</td><td colspan="1" rowspan="1">1.05</td></tr><tr><td colspan="1" rowspan="1">Body Mass Index (kg/m<sup>2</sup>)</td><td colspan="1" rowspan="1">0.98</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">0.81</td><td colspan="1" rowspan="1">1.23</td></tr><tr><td colspan="1" rowspan="1">Number of years of education (yrs)</td><td colspan="1" rowspan="1">0.93</td><td colspan="1" rowspan="1">0.99</td><td colspan="1" rowspan="1">0.77</td><td colspan="1" rowspan="1">1.28</td></tr><tr><td colspan="1" rowspan="1">T0 MMSE</td><td colspan="1" rowspan="1"><bold>0.01</bold><xref rid="tf0005" ref-type="table-fn">⁎</xref></td><td colspan="1" rowspan="1">1.91</td><td colspan="1" rowspan="1">1.15</td><td colspan="1" rowspan="1">3.17</td></tr><tr><td colspan="1" rowspan="1">Total number of comorbidities</td><td colspan="1" rowspan="1">0.65</td><td colspan="1" rowspan="1">0.94</td><td colspan="1" rowspan="1">0.73</td><td colspan="1" rowspan="1">1.22</td></tr><tr><td colspan="1" rowspan="1">counting gait velocity (m/s)</td><td colspan="1" rowspan="1"><bold>0.02</bold><xref rid="tf0005" ref-type="table-fn">⁎</xref></td><td colspan="1" rowspan="1">0.95</td><td colspan="1" rowspan="1">0.90</td><td colspan="1" rowspan="1">0.99</td></tr><tr><td colspan="1" rowspan="1">WMH (cm<sup>3</sup>)</td><td colspan="1" rowspan="1"><bold>0.03</bold><xref rid="tf0005" ref-type="table-fn">⁎</xref></td><td colspan="1" rowspan="1">1.20</td><td colspan="1" rowspan="1">1.02</td><td colspan="1" rowspan="1">1.42</td></tr></tbody></table><table-wrap-foot><fn id="tf0005"><label>⁎</label><p id="np0005">Significant at the <italic toggle="yes">p</italic> &lt; .05 level (in bold); IRR: Incident Rate Ratios.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Parameters estimates for negative binomial regression with multiple predictors.</div>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Parameter</th><th rowspan="2">Sig.</th><th rowspan="2">IRR</th><th colspan="2">95% Confidence Interval for IRR</th></tr><tr><th>Lower</th><th>Upper</th></tr></thead><tbody><tr><td>RD ForcepsMin (107 μm2/s)</td><td>0.02???</td><td>1.02</td><td>1.00</td><td>1.04</td></tr><tr><td>Gender</td><td>0.12</td><td>3.24</td><td>0.74</td><td>14.18</td></tr><tr><td>Age (yrs)</td><td>0.16</td><td>0.89</td><td>0.75</td><td>1.05</td></tr><tr><td>Body Mass Index (kg/m2)</td><td>0.98</td><td>1.00</td><td>0.81</td><td>1.23</td></tr><tr><td>Number of years of education (yrs)</td><td>0.93</td><td>0.99</td><td>0.77</td><td>1.28</td></tr><tr><td>T0 MMSE</td><td>0.01???</td><td>1.91</td><td>1.15</td><td>3.17</td></tr><tr><td>Total number of comorbidities</td><td>0.65</td><td>0.94</td><td>0.73</td><td>1.22</td></tr><tr><td>counting gait velocity (m/s)</td><td>0.02???</td><td>0.95</td><td>0.90</td><td>0.99</td></tr><tr><td>WMH (cm3)</td><td>0.03???</td><td>1.20</td><td>1.02</td><td>1.42</td></tr></tbody></table></div>⁎Significant at the p &lt; .05 level (in bold); IRR: Incident Rate Ratios.</transformed-table></extracted-table></extracted-tables-set>